CLINICAL SUPPLY MANAGEMENT ARTICLES
Who Decides When The Comparator Changes?
Clinical trial comparator sourcing can affect patient treatment and study design. Learn when comparator changes become clinical decisions and who should own them.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Supply disruptions are becoming harder to predict. Explore practical strategies for continuity planning, supplier risk management, and network design to build lasting resilience.
-
An inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases.
-
Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.
-
Gain insight into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies.
-
Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
-
Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?
-
How can investing in suitable tech solutions enhance efficiency and reduce companies' carbon footprint?